Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Merck
Cantor Fitzgerald
Harvard Business School
Baxter
Argus Health
Accenture
McKesson
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040409

« Back to Dashboard

NDA 040409 describes ANEXSIA 5/325, which is a drug marketed by Specgx Llc and is included in one NDA. It is available from seven suppliers. Additional details are available on the ANEXSIA 5/325 profile page.

The generic ingredient in ANEXSIA 5/325 is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for 040409
Tradename:ANEXSIA 5/325
Applicant:Specgx Llc
Ingredient:acetaminophen; hydrocodone bitartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040409
Mechanism of ActionOpioid Agonists
Suppliers and Packaging for NDA: 040409
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANEXSIA 5/325 acetaminophen; hydrocodone bitartrate TABLET;ORAL 040409 ANDA SpecGx LLC 0406-0123 N 0406-0123-62
ANEXSIA 5/325 acetaminophen; hydrocodone bitartrate TABLET;ORAL 040409 ANDA SpecGx LLC 0406-0123 N 0406-0123-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;5MG
Approval Date:Oct 20, 2000TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Daiichi Sankyo
Julphar
Express Scripts
Healthtrust
Harvard Business School
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.